Skip to main content
logo
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.000
+0.049 (5.12%)
At close: Oct 28, 2026, 4:00 PM EDT
1.040
+0.040 (4.00%)
After-hours: Oct 28, 2026, 5:28 PM EDT

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $681.58K in the quarter ending June 30, 2026, a decrease of -20.86%. This brings the company's total for the last twelve months to $3.77M, down -30.04% year-over-year. In the year 2025, Marker Therapeutics had annual revenue of $3.55M, down -46.19%. That makes Marker Therapeutics the 40,997th largest company in the world by revenue and 5,504th in the United States.

Revenue (ttm)
$3.77M
Revenue Growth
-30.04%
P/S Ratio
4.70
Revenue / Employee
$709,334
Employees
5
Market Cap
16.67M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.55M-3.04M-46.19%
Dec 31, 20246.59M3.28M99.06%
Dec 31, 20233.31M-5.70M-63.26%
Dec 31, 20229.01M7.77M625.90%
Dec 31, 20211.24M774.93K166.01%
Dec 31, 2020466.79K253.59K118.95%
Dec 31, 2019213.19K7.20K3.50%
Dec 31, 2018205.99K22.93K12.53%
Dec 31, 2017183.06K-48.14K-20.82%
Dec 31, 2016231.20K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Kyntra Bio4.62M
Dyadic International3.80M
Seres Therapeutics1.88M
Neuphoria Therapeutics1.17M
Pluri1.02M
Allarity Therapeutics345.00K
Kiora Pharmaceuticals20.00K
BioCardia3.00K
Revenue Rankings

MRKR News

More News